global preclinical imaging in vivo systems n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Global Preclinical Imaging In-VIVO Systems and Reagents Market Share will Increase US $ 960 Million By 2022 PowerPoint Presentation
Download Presentation
Global Preclinical Imaging In-VIVO Systems and Reagents Market Share will Increase US $ 960 Million By 2022

Loading in 2 Seconds...

play fullscreen
1 / 5

Global Preclinical Imaging In-VIVO Systems and Reagents Market Share will Increase US $ 960 Million By 2022 - PowerPoint PPT Presentation


  • 0 Views
  • Uploaded on

The preclinical imaging in vivo systems and reagents Market is expected to exceed more than US $ 960 million by 2022 and will grow at a CAGR of more than 6% in the given forecast period.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

Global Preclinical Imaging In-VIVO Systems and Reagents Market Share will Increase US $ 960 Million By 2022


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
global preclinical imaging in vivo systems

Global Preclinical Imaging In-VIVO Systems and Reagents Market Share will Increase US $ 960 Million By2022

  • Market Research Engine has published a new report titled as “Preclinical Imaging In- VIVO Systems And Reagents Market By Modality Analysis; By Reagents Analysis and By Regional Analysis – Global Forecast by 2016 -2022”
  • The preclinical imaging in vivo systems and reagents Market is expected to exceed more than US $ 960 million by 2022 and will grow at a CAGR of more than 6% in the given forecast period.
  • Browse Full Report: https://www.marketresearchengine.com/reportdetails/preclinical- imaging-in-vivo-systems-and-reagents-market
  • Preclinical imaging is the visualization of residing animals for studies purposes, which include drug development. Imaging modalities have long been critical to the researcher in observing modifications, both at the organ, tissue, mobile, or molecular level, in animals responding to physiological or environmental modifications. Imaging modalities which are non-invasive and In-VIVO have turn out to be particularly critical to take a look at animal fashions longitudinally. These imaging systems may be labeled into commonly morphological/anatomical and commonly molecular imaging techniques. Strategies along with high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are normally used for anatomical imaging. Whilst optical imaging (fluorescence and bioluminescence), positron emission tomography (puppy), and single photon emission computed tomography (SPECT) are typically used for molecular visualizations.
  • The major driving factors of Global Preclinical Imaging IN-VIVO Systems and Reagents Market are asfollows:
  • Technical advancements in the area of molecularimaging
  • Growing market demand for noninvasive small animal imagingtechniques
  • Increasing number of public and private initiative and financial support to support preclinicalresearches
  • The restraining factors of Global Preclinical Imaging In-VIVO Systems and Reagents Market are asfollows:
  • Strict rules leading preclinical research
  • Major installation and operational cost related withpreclinical
the global preclinical imaging in vivo systems

The Global Preclinical Imaging In-VIVO Systems and Reagents Market is segmented on the lines of its modality, reagents and regional. Based on modality segmentation it covers optical imaging systems, standalone fluorescence imaging systems, bioluminescence/fluorescence imaging systems, optical + X-Ray/optical + CT, micro-PET systems, preclinical nuclear imaging systems, micro-MRI systems, trimodality (SPECT/PET/CT) systems, micro-SPECT systems Micro-CT systems, micro-ultrasound systems, preclinical magnetic particle imaging (MPI) systems and preclinical photo acoustic imaging systems. Under reagents segmentation it covers preclinical optical imaging reagents, fluorescent imaging reagents, bioluminescent imaging reagents, preclinical nuclear imaging reagents, preclinical SPECT probes, preclinical MRI contrast agents, preclinical PET tracers, gadolinium-based preclinical MRI contrast agents, manganese-based preclinical MRI contrast agents, iron-based preclinical MRI contrast agents, preclinical CT contrast agents, barium-based preclinical CT contrast agents, preclinical ultrasound contrast agents, gold nano particles, iodine-based preclinical CT contrast agents and gastrografin- based preclinical CT contrast agents. The Global Preclinical Imaging In-VIVO Systems and Reagents market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCCcountries.

This reportprovides:

An overview of the global market for Global Preclinical Imaging In-VIVO Systems and Reagents Market and relatedtechnologies.

Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through2022.

Identifications of new market opportunities and targeted promotional plans forGlobal

Preclinical Imaging in Vivo Systems and ReagentsMarket.

Discussion of research and development, and the demand for new products and new applications.

Comprehensive company profiles of major players in theindustry.

REPORTSCOPE:

The scope of the report includes a detailed study of global and regional markets for Global Preclinical Imaging In-VIVO Systems and Reagents Market with the reasons given for variations in the growth of the industry in certainregions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Aspect Imaging Ltd, Bruker Corporation, Fujifilm Holdings Corporation, Li-Cor Biosciences, MR Solutions Ltd., Mediso Ltd., Milabs B.V., MiltenyiBiotec GmbH, Perkinelmer and Trifoil Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and currentdevelopments.

The Global Preclinical Imaging In-VIVO Systems and Reagents Markethasbeen

segmented as below by modality analysis optical

segmented asbelow:

  • By Modality Analysis
  • Optical ImagingSystems
  • Standalone Fluorescence ImagingSystems
  • Bioluminescence/Fluorescence ImagingSystems
  • Optical + X-Ray/Optical +CT
  • Micro-PETSystems
  • Preclinical Nuclear ImagingSystems
  • Micro-MRISystems
  • Trimodality (SPECT/PET/CT) Systems
  • Micro-SPECT Systems Micro-CTSystems
  • Micro-Ultrasound Systems
  • Preclinical Magnetic Particle Imaging (MPI)Systems
  • Preclinical Photo acoustic ImagingSystems
  • By ReagentsAnalysis
  • Preclinical Optical ImagingReagents
  • Fluorescent Imaging Reagents
  • Bioluminescent ImagingReagents
  • Preclinical Nuclear ImagingReagents
  • Preclinical SPECTProbes
  • Preclinical MRI Contrast Agents
  • Preclinical PETTracers
  • Gadolinium-based Preclinical MRI ContrastAgents
  • Manganese-based Preclinical MRI ContrastAgents
  • Iron-based Preclinical MRI ContrastAgents
  • Preclinical CT ContrastAgents
  • Barium-based Preclinical CT ContrastAgents
  • Preclinical Ultrasound ContrastAgents
  • Gold Nanoparticles
  • Iodine-based Preclinical CT ContrastAgents
  • Gastrografin-based Preclinical CT ContrastAgents
  • By RegionalAnalysis
  • North America
  • Europe
  • Asia-Pacific
  • Rest of theWorld
request sample report https

Request Sample Report: https://www.marketresearchengine.com/reportdetails/preclinical-imaging-in-vivo-systems- and-reagents-market

Table ofContents

  • INTRODUCTION
  • ResearchMethodology
  • ExecutiveSummary
  • PremiumInsights
  • Preclinical Imaging Market Overview 6 IndustryInsights
  • 7 Global Preclinical Imaging Market, By Modality 8 Global Preclinical Imaging Market, By Reagent 9 Preclinical Imaging Market, ByRegion
  • CompetitiveLandscape
  • CompanyProfiles
    • Introduction
    • Perkinelmer,Inc.
    • BrukerCorporation
    • Fujifilm HoldingsCorporation
    • MedisoLtd.
    • MilabsB.V.
    • MR SolutionsLtd.
    • Aspect ImagingLtd.
    • Li-CorBiosciences
    • TrifoilImaging
11 11 miltenyi biotec gmbh

11.11 Miltenyi BiotecGmbH

Reasons to Buy thisReport:

Obtain the most up to date information available on all Global Preclinical Imaging In- VIVO Systems and ReagentsMarket.

Identify growth segments and opportunities in theindustry.

Facilitate decision making on the basis of strong historic and forecast of Global Preclinical Imaging In-VIVO Systems and Reagents Marketdata.

Assess your competitor’s refining portfolio and itsevolution.

AboutMarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop businessstrategies.

MediaContact

Company Name: Market ResearchEngine

Contact Person: JohnBay

Email:john@marketresearchengine.com

Phone: +1-855-984-1862

Country: UnitedStates

Website:https://www.marketresearchengine.com/